butyric acid has been researched along with Adenocarcinoma in 72 studies
Butyric Acid: A four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
butyrate : A short-chain fatty acid anion that is the conjugate base of butyric acid, obtained by deprotonation of the carboxy group.
butyric acid : A straight-chain saturated fatty acid that is butane in which one of the terminal methyl groups has been oxidised to a carboxy group.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 7.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "In the present study, we have examined the neutral glycolipids, gangliosides, and sulfoglycolipids of human rectal adenocarcinoma (HRT-18) cells and the alterations produced by the differentiating agents, sodium butyrate, dimethyl sulfoxide, and retinoic acid." | 7.67 | Effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on glycolipids of human rectal adenocarcinoma cells. ( Kim, YS; Siddiqui, B, 1984) |
| "The effects of sodium butyrate, dimethyl sulfoxide (DMSO), and retinoic acid on the growth, morphology, carcinoembryonic antigen content, cell surface membrane-associated enzyme activities, and glycoprotein profiles of a human rectal adenocarcinoma cell line (HRT-18) in culture were compared." | 7.66 | Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells. ( Bella, A; Kim, YS; Luu, P; Morita, A; Tsao, D, 1982) |
| " Therefore, this study evaluated the anti-proliferative effects of three key gut microbial metabolites-sodium butyrate, inosine, and nisin, against MCF7 and MDA-MB-231 breast adenocarcinoma cell lines." | 4.31 | Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells. ( Alsherbiny, MA; Bhuyan, DJ; Chang, D; Jaye, K; Li, CG, 2023) |
| " The aim of the present study was to elucidate the probable mechanisms involved in the beneficial effects of a fiber-supplemented diet (5% Plantago ovata seeds) in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis, with special attention to its effects on the production of some of the mediators involved in the inflammatory response, such as tumor necrosis factor alpha (TNFalpha) and nitric oxide (NO)." | 3.71 | Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. ( Azzouz, S; Camuesco, D; Concha, A; Gálvez, J; Lorente, MD; Osuna, A; Redondo, L; Rodríguez-Cabezas, ME; Zarzuelo, A, 2002) |
| "We previously demonstrated that two human pancreatic adenocarcinoma cell lines, CFPAC-1 (established from a patient with cystic fibrosis) and CAPAN-1, were able to secrete trypsinogens 1 and 2 specifically." | 3.69 | Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth. ( Figarella, C; Guy-Crotte, O; Merten, M; Miszczuk-Jamska, B; Renaud, W, 1994) |
| "It has previously been observed that allyl isothiocyanate, a compound naturally present in the diet, is more cytotoxic toward the human colorectal adenocarcinoma cell line HT29 in its control transformed state than after exposure to sodium butyrate or to dimethylformamide, which slow growth and induce differentiation (detransformation)." | 3.69 | Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29. ( Fyfe, D; Johnson, IT; Musk, SR; Smith, TK; Stening, P; Stephenson, P, 1995) |
| "A low concentration of differentiation inducers such as dimethylsulphoxide (DMSO), sodium butyrate, hexamethylene bisacetamide and sodium phenylacetate greatly enhanced the antiproliferative effect in vitro and in vivo of interferon alpha (IFN-alpha) to several human lung adenocarcinoma cells." | 3.69 | Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents. ( Goto, I; Honma, Y; Yamamoto-Yamaguchi, Y, 1996) |
| " TMCC-1, uterine cervical adenocarcinoma cells, were exposed to dexamethasone (DEX), sodium n-butyrate (NaB), dibutyryl cyclic AMP (dbcAMP), retinoic acid (RA), calcitriol (VD3), and interferon-gamma (IFN-gamma)." | 3.68 | Changes in CA125 release and surface expression caused by drugs in uterine cervix adenocarcinoma cells. ( Endo, K; Hosono, M; Kobayashi, H; Konishi, J; Nakai, T; Saga, T; Sakahara, H; Sakamoto, M; Shirato, M, 1993) |
| "We developed a mitomycin C (MMC)-resistant human lung adenocarcinoma cell subline, SPC-A1/DM4, from cloned SPC-A1/D13 parent cells by 1 h exposures to escalating concentrations of the drug over 17 months." | 3.68 | Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. ( Dong, QG; Gong, LL; Wang, EZ; Wang, HJ, 1993) |
| "In the present study, we have examined the neutral glycolipids, gangliosides, and sulfoglycolipids of human rectal adenocarcinoma (HRT-18) cells and the alterations produced by the differentiating agents, sodium butyrate, dimethyl sulfoxide, and retinoic acid." | 3.67 | Effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on glycolipids of human rectal adenocarcinoma cells. ( Kim, YS; Siddiqui, B, 1984) |
| "We have found that the differentiation inducer butyric acid causes the synthesis of a cellular protein(s) that mediates a rapid decline in the level of myc RNA in SW837, a cell line derived from a human adenocarcinoma of the rectum." | 3.67 | Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. ( Herold, KM; Rothberg, PG, 1988) |
| "The effects of sodium butyrate, dimethyl sulfoxide (DMSO), and retinoic acid on the growth, morphology, carcinoembryonic antigen content, cell surface membrane-associated enzyme activities, and glycoprotein profiles of a human rectal adenocarcinoma cell line (HRT-18) in culture were compared." | 3.66 | Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells. ( Bella, A; Kim, YS; Luu, P; Morita, A; Tsao, D, 1982) |
| "Human colorectal cancer cell lines (HCT-116 and HT-29) were treated with sodium butyrate at concentrations ranging from 0." | 1.43 | Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis. ( Chen, J; Chen, S; Chu, X; Deng, H; Gong, M; Li, C; Li, Z; Mao, L; Sun, S; Yi, M; Zha, L; Zhang, J; Zhang, Z, 2016) |
| "In this study we used colon cancer cell lines to study the cellular and molecular events that take place during co-treatment with NaB, EC and EGCG." | 1.39 | Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1. ( Cascante, M; Centelles, JJ; Dudeja, PK; Sánchez-Tena, S; Vizán, P, 2013) |
| "Thus, we have tested polyposis coli Pc/AA adenoma cells, Caco-2, HT-29 and LS174T adenocarcinoma cell lines." | 1.31 | Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. ( Chastre, E; Gazit, A; Gespach, C; Halperin, M; Mashiah, P; Vider, BZ; Yaniv, A; Zimber, A, 2000) |
| "n-Butyrate inhibits the growth of colon cancer cell lines." | 1.30 | Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. ( Eastman, A; McBain, JA; Mueller, GC; Nobel, CS, 1997) |
| "Other colon cancer cell lines were examined for the extent of cell death following treatment with TPA/butyrate." | 1.29 | Phorbol ester augments butyrate-induced apoptosis of colon cancer cells. ( Eastman, A; McBain, JA; Mueller, GC; Pettit, GR; Simmons, DL, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (29.17) | 18.7374 |
| 1990's | 36 (50.00) | 18.2507 |
| 2000's | 6 (8.33) | 29.6817 |
| 2010's | 7 (9.72) | 24.3611 |
| 2020's | 2 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Jaye, K | 1 |
| Alsherbiny, MA | 1 |
| Chang, D | 1 |
| Li, CG | 1 |
| Bhuyan, DJ | 1 |
| Cambria, MT | 1 |
| Villaggio, G | 1 |
| Laudani, S | 1 |
| Pulvirenti, L | 1 |
| Federico, C | 1 |
| Saccone, S | 1 |
| Condorelli, GG | 1 |
| Sinatra, F | 1 |
| Rawłuszko, AA | 1 |
| Antoniucci, M | 1 |
| Horbacka, K | 1 |
| Lianeri, M | 1 |
| Krokowicz, P | 1 |
| Jagodziński, PP | 1 |
| Sánchez-Tena, S | 1 |
| Vizán, P | 1 |
| Dudeja, PK | 2 |
| Centelles, JJ | 1 |
| Cascante, M | 1 |
| Zhang, J | 1 |
| Yi, M | 1 |
| Zha, L | 1 |
| Chen, S | 1 |
| Li, Z | 1 |
| Li, C | 1 |
| Gong, M | 1 |
| Deng, H | 1 |
| Chu, X | 1 |
| Chen, J | 1 |
| Zhang, Z | 1 |
| Mao, L | 1 |
| Sun, S | 1 |
| Hichino, A | 1 |
| Okamoto, M | 1 |
| Taga, S | 1 |
| Akizuki, R | 1 |
| Endo, S | 1 |
| Matsunaga, T | 1 |
| Ikari, A | 1 |
| Guo, R | 1 |
| Zhang, Y | 1 |
| Liang, S | 1 |
| Xu, H | 1 |
| Zhang, M | 1 |
| Li, B | 1 |
| Almaraz, RT | 1 |
| Aich, U | 1 |
| Khanna, HS | 1 |
| Tan, E | 1 |
| Bhattacharya, R | 1 |
| Shah, S | 1 |
| Yarema, KJ | 1 |
| Humphreys, KJ | 1 |
| Cobiac, L | 1 |
| Le Leu, RK | 1 |
| Van der Hoek, MB | 1 |
| Michael, MZ | 1 |
| Rodríguez-Cabezas, ME | 1 |
| Gálvez, J | 2 |
| Lorente, MD | 1 |
| Concha, A | 1 |
| Camuesco, D | 1 |
| Azzouz, S | 1 |
| Osuna, A | 1 |
| Redondo, L | 1 |
| Zarzuelo, A | 2 |
| Alrefai, WA | 1 |
| Tyagi, S | 1 |
| Gill, R | 1 |
| Saksena, S | 1 |
| Hadjiagapiou, C | 1 |
| Mansour, F | 1 |
| Ramaswamy, K | 1 |
| Fu, H | 1 |
| Shi, YQ | 1 |
| Mo, SJ | 1 |
| Comalada, M | 1 |
| Bailón, E | 1 |
| de Haro, O | 1 |
| Lara-Villoslada, F | 1 |
| Xaus, J | 1 |
| Siddiqui, B | 1 |
| Kim, YS | 6 |
| Tsao, D | 2 |
| Shi, ZR | 1 |
| Wong, A | 1 |
| Morita, A | 1 |
| Bella, A | 1 |
| Luu, P | 1 |
| Herz, F | 1 |
| Halwer, M | 1 |
| Li, M | 1 |
| Andersen, V | 1 |
| Lance, P | 1 |
| Jacewicz, MS | 1 |
| Acheson, DW | 1 |
| Mobassaleh, M | 1 |
| Donohue-Rolfe, A | 1 |
| Balasubramanian, KA | 1 |
| Keusch, GT | 1 |
| Krupitza, G | 1 |
| Harant, H | 1 |
| Dittrich, E | 1 |
| Szekeres, T | 1 |
| Huber, H | 1 |
| Dittrich, C | 1 |
| Miszczuk-Jamska, B | 1 |
| Merten, M | 1 |
| Renaud, W | 1 |
| Guy-Crotte, O | 1 |
| Figarella, C | 1 |
| Corra, S | 1 |
| Kazakoff, K | 1 |
| Mogaki, M | 1 |
| Cano, M | 1 |
| Pour, PM | 1 |
| Ho, SB | 2 |
| Yan, PS | 1 |
| Dahiya, R | 1 |
| Neuschwander-Tetri, BA | 1 |
| Basbaum, C | 1 |
| Perrin, P | 1 |
| Cassagnau, E | 1 |
| Burg, C | 1 |
| Patry, Y | 1 |
| Vavasseur, F | 1 |
| Harb, J | 1 |
| Le Pendu, J | 1 |
| Douillard, JY | 1 |
| Galmiche, JP | 1 |
| Bornet, F | 1 |
| Nakai, T | 2 |
| Sakahara, H | 2 |
| Endo, K | 2 |
| Shirato, M | 1 |
| Kobayashi, H | 1 |
| Hosono, M | 1 |
| Saga, T | 1 |
| Sakamoto, M | 1 |
| Konishi, J | 2 |
| Gope, R | 1 |
| Gope, ML | 1 |
| Dong, QG | 1 |
| Gong, LL | 1 |
| Wang, HJ | 1 |
| Wang, EZ | 1 |
| Yabushita, H | 2 |
| Sartorelli, AC | 1 |
| Barnard, JA | 1 |
| Warwick, G | 1 |
| Souleimani, A | 1 |
| Asselin, C | 1 |
| Desai, TK | 1 |
| Nathan, DF | 1 |
| Morin, MJ | 1 |
| Kvale, D | 1 |
| Brandtzaeg, P | 1 |
| Musk, SR | 1 |
| Stephenson, P | 1 |
| Smith, TK | 1 |
| Stening, P | 1 |
| Fyfe, D | 1 |
| Johnson, IT | 1 |
| Goto, I | 1 |
| Yamamoto-Yamaguchi, Y | 1 |
| Honma, Y | 1 |
| McBain, JA | 2 |
| Eastman, A | 2 |
| Simmons, DL | 1 |
| Pettit, GR | 1 |
| Mueller, GC | 2 |
| Ishima, R | 1 |
| Akasaka, K | 1 |
| Russo, GL | 1 |
| Della Pietra, V | 1 |
| Mercurio, C | 1 |
| Della Ragione, F | 1 |
| Marshak, DR | 1 |
| Oliva, A | 1 |
| Zappia, V | 1 |
| Nobel, CS | 1 |
| Navarro, JM | 1 |
| Olmo, N | 1 |
| Turnay, J | 1 |
| López-Conejo, MT | 1 |
| Lizarbe, MA | 1 |
| Noguchi, M | 1 |
| Nakanishi, M | 1 |
| Yamane, M | 1 |
| Shimizu, S | 1 |
| Abe, A | 1 |
| Yamane, S | 1 |
| Moore-Hoon, ML | 1 |
| Turner, RJ | 1 |
| Nishimura, A | 1 |
| Fujimoto, M | 1 |
| Oguchi, S | 1 |
| Fusunyan, RD | 1 |
| MacDermott, RP | 1 |
| Sanderson, IR | 1 |
| Vider, BZ | 1 |
| Zimber, A | 1 |
| Chastre, E | 1 |
| Gespach, C | 1 |
| Halperin, M | 1 |
| Mashiah, P | 1 |
| Yaniv, A | 1 |
| Gazit, A | 1 |
| Coradini, D | 1 |
| Pellizzaro, C | 1 |
| Marimpietri, D | 1 |
| Abolafio, G | 1 |
| Daidone, MG | 1 |
| Gamet, L | 1 |
| Daviaud, D | 1 |
| Denis-Pouxviel, C | 1 |
| Remesy, C | 1 |
| Murat, JC | 1 |
| Hay, FG | 2 |
| Duncan, LW | 1 |
| Langdon, SP | 2 |
| Leonard, RC | 2 |
| Brooks, SE | 1 |
| Timmerman, J | 1 |
| Lau, CC | 1 |
| Tsao, SW | 1 |
| Knapp, RC | 1 |
| Sheets, EE | 1 |
| Saito, S | 3 |
| Crissman, HA | 1 |
| Nishijima, M | 2 |
| Kagabu, T | 3 |
| Nishiya, I | 3 |
| Cram, LS | 1 |
| Awad, AB | 1 |
| Horvath, PJ | 1 |
| Andersen, MS | 1 |
| Lü, GZ | 2 |
| Gao, Y | 2 |
| Zhou, LX | 1 |
| Lin, ZX | 2 |
| Zheng, Y | 1 |
| Mullins, TD | 1 |
| Kern, HF | 1 |
| Metzgar, RS | 1 |
| Walling, JM | 1 |
| Blackmore, M | 1 |
| Hickman, JA | 1 |
| Townsend, KM | 1 |
| Ji, QS | 1 |
| Chen, HY | 1 |
| Sato, M | 2 |
| Fukushima, A | 1 |
| Ono, H | 1 |
| Fujimoto, J | 1 |
| Okada, H | 1 |
| Arundel, CM | 3 |
| Leith, JT | 3 |
| Sussman, NL | 1 |
| Eliakim, R | 1 |
| Rubin, D | 1 |
| Perlmutter, DH | 1 |
| DeSchryver-Kecskemeti, K | 1 |
| Alpers, DH | 1 |
| Huang, YC | 1 |
| Wang, KR | 1 |
| Toribara, NW | 1 |
| Sack, TL | 1 |
| Gum, JR | 2 |
| Shively, JE | 1 |
| Willson, JK | 1 |
| Otaka, M | 1 |
| Singhal, A | 1 |
| Hakomori, S | 1 |
| Bryant, G | 1 |
| Haberern, C | 1 |
| Rao, CN | 1 |
| Liotta, LA | 1 |
| Azuma, M | 1 |
| Hayashi, Y | 1 |
| Yoshida, H | 1 |
| Yanagawa, T | 1 |
| Yura, Y | 1 |
| Ueno, A | 1 |
| Chang, CC | 1 |
| Chao, KC | 1 |
| Ng, HT | 1 |
| Herold, KM | 1 |
| Rothberg, PG | 1 |
| Hawkes, MM | 1 |
| Lawrie, SS | 1 |
| Schol, DJ | 1 |
| Hilgers, J | 1 |
| Smyth, JF | 1 |
| el-Deriny, SE | 1 |
| O'Brien, MJ | 1 |
| Christensen, TG | 1 |
| Kupchik, HZ | 1 |
| Kenney, SM | 1 |
| Glicksman, AS | 2 |
| Kam, WK | 1 |
| Byrd, JC | 1 |
| Hicks, JW | 1 |
| Sleisenger, MH | 1 |
| Reese, DH | 1 |
| Gratzner, HG | 1 |
| Block, NL | 1 |
| Politano, VA | 1 |
| Nozawa, S | 1 |
| Tsai, DZ | 1 |
| Sakayori, M | 1 |
| Iizuka, R | 1 |
| Nishimura, R | 1 |
| Mochizuki, M | 1 |
72 other studies available for butyric acid and Adenocarcinoma
| Article | Year |
|---|---|
Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells.
Topics: Adenocarcinoma; Butyric Acid; Gastrointestinal Microbiome; Humans; Inosine; Nisin; Reactive Oxygen S | 2023 |
The Interplay between Fe
Topics: Adenocarcinoma; Antineoplastic Agents; Butyric Acid; Cell Line; Cell Line, Tumor; Cell Survival; Col | 2020 |
Reduced expression of steroid sulfatase in primary colorectal cancer.
Topics: Adenocarcinoma; Aged; Butyric Acid; Cell Line, Tumor; Colon; Colorectal Neoplasms; Female; Humans; I | 2013 |
Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.
Topics: Adenocarcinoma; Alkaline Phosphatase; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Butyric | 2013 |
Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells: Implications for Apoptosis.
Topics: Adenocarcinoma; Apoptosis; Autophagy; Blotting, Western; Butyric Acid; Cell Proliferation; Colorecta | 2016 |
Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Azacitidine; Butyric Acid; Cell Proliferation; C | 2017 |
Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Baculoviridae; Biological Transport; Blotting, Western; Buty | 2010 |
Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
Topics: Acylation; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Azides; Breast Neoplasms; Buty | 2012 |
Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Apoptosis Regulatory Proteins; Bcl-2-Like Prot | 2013 |
Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats.
Topics: Adenocarcinoma; Animals; Butyric Acid; Colitis; Colon; Colonic Neoplasms; Dietary Fiber; Female; Glu | 2002 |
Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate.
Topics: Adenocarcinoma; Butyric Acid; Caco-2 Cells; Carcinogens; Colonic Neoplasms; Drug Administration Sche | 2004 |
Effect of short-chain fatty acids on the proliferation and differentiation of the human colonic adenocarcinoma cell line Caco-2.
Topics: Acetic Acid; Adenocarcinoma; Butyric Acid; Caco-2 Cells; Cell Differentiation; Cell Movement; Cell P | 2004 |
The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Apoptosis; Blotting, Western; Butyric Acid; Cell Prol | 2006 |
Effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on glycolipids of human rectal adenocarcinoma cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Line; Chromatography, Thin Layer; Dimethyl Sulfoxide; | 1984 |
Effect of sodium butyrate on carcinoembryonic antigen production by human colonic adenocarcinoma cells in culture.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Line; Colonic Neoplasms; Gly | 1983 |
Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Surface; Butyrates; Butyric Acid; Cell Division; Cell | 1982 |
Synergistic induction of alkaline phosphatase in colonic carcinoma cells by sodium butyrate and hyperosmolality.
Topics: Adenocarcinoma; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Line; Colonic Neoplasms; Enzyme | 1982 |
Expression and regulation of glycosyltransferases for N-glycosyl oligosaccharides in fresh human surgical and murine tissues and cultured cell lines.
Topics: Adenocarcinoma; Animals; beta-D-Galactoside alpha 2-6-Sialyltransferase; Blotting, Northern; Butyrat | 1995 |
Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells.
Topics: Adenocarcinoma; Bacterial Toxins; Butyrates; Butyric Acid; Cell Line; Cell Survival; Colonic Neoplas | 1995 |
Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells.
Topics: Adenocarcinoma; Base Sequence; Blotting, Northern; Butyrates; Butyric Acid; Cell Line; Cell Nucleus; | 1995 |
Trypsinogen expression by two human pancreatic cell lines CFPAC-1 and CAPAN-1. Modulation during spontaneous and induced cell growth.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Dexamethasone; Dimethyl Sulfoxide; Humans; P | 1994 |
Modification of antigen expression in human and hamster pancreatic cancer cell lines induced by sodium butyrate.
Topics: ABO Blood-Group System; Adenocarcinoma; Animals; Antigens, Neoplasm; Blood Group Antigens; Butyrates | 1993 |
Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.
Topics: Adenocarcinoma; Aminopeptidases; Animals; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subf | 1994 |
An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.
Topics: Adenocarcinoma; Animals; Antigen-Presenting Cells; Butyrates; Butyric Acid; Colonic Neoplasms; Combi | 1994 |
Changes in CA125 release and surface expression caused by drugs in uterine cervix adenocarcinoma cells.
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Bucladesine; Butyrates; Butyric Acid; Calc | 1993 |
Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Differentiation; Colonic Neoplasms; Depression, Chemic | 1993 |
Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Cell Survival; Cisplatin; DNA, Neoplasm; Dru | 1993 |
Effects of sodium butyrate, dimethylsulfoxide and dibutyryl cAMP on the poorly differentiated ovarian adenocarcinoma cell line AMOC-2.
Topics: Adenocarcinoma; Alkaline Phosphatase; Bucladesine; Butyrates; Butyric Acid; Cell Differentiation; Cy | 1993 |
Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; | 1993 |
Regulation of C-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2.
Topics: Activating Transcription Factors; Adenocarcinoma; Base Sequence; Blood Proteins; Butyrates; Butyric | 1993 |
Potentiation of butyrate-induced differentiation in human colon tumor cells by deoxycholate.
Topics: Adenocarcinoma; Alkaline Phosphatase; beta-Galactosidase; Butyrates; Butyric Acid; Cell Differentiat | 1993 |
Butyrate differentially affects constitutive and cytokine-induced expression of HLA molecules, secretory component (SC), and ICAM-1 in a colonic epithelial cell line (HT-29, clone m3).
Topics: Adenocarcinoma; Antigens, Neoplasm; Bacteria, Anaerobic; Butyrates; Butyric Acid; Cell Division; Col | 1995 |
Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29.
Topics: Adenocarcinoma; Allyl Compounds; Anticarcinogenic Agents; Butyrates; Butyric Acid; Cell Differentiat | 1995 |
Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
Topics: Acetamides; Adenocarcinoma; Alkaline Phosphatase; Animals; Antineoplastic Agents; Biomarkers; Butyra | 1996 |
Phorbol ester augments butyrate-induced apoptosis of colon cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Bryostatins; Butyrates; Butyric Acid; Cell Divisio | 1996 |
1H-magnetic resonance spectroscopic observation of cultured malignant cells pharmacologically induced to different phenotypes.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Butyrates; Butyric Acid; Cho | 1996 |
Down-regulation of protein kinase CKII activity by sodium butyrate.
Topics: Adenocarcinoma; Amino Acid Sequence; Butyrates; Butyric Acid; Casein Kinase II; Cell Differentiation | 1997 |
Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
Topics: Adenocarcinoma; Apoptosis; Butyrates; Butyric Acid; Colonic Neoplasms; Dose-Response Relationship, D | 1997 |
Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5'-nucleotidase activity.
Topics: 5'-Nucleotidase; Adenocarcinoma; Apoptosis; Biomarkers, Tumor; Butyrates; Butyric Acid; Carcinoembry | 1997 |
Emergence of an irreversible differentiated subclone from the poorly differentiated ovarian adenocarcinoma cell line AMOC-2 treated with sodium butyrate.
Topics: Adenocarcinoma; Animals; Blotting, Western; Butyrates; Butyric Acid; Cell Count; Cell Differentiatio | 1997 |
Docosahexaenoic/arachidonic acid omega-hydroxylation system and differentiation in the human colonic adenocarcinoma cell line, Caco-2.
Topics: Adenocarcinoma; Alkaline Phosphatase; Arachidonic Acid; Butyrates; Butyric Acid; Caco-2 Cells; Cell | 1998 |
Increased expression of the secretory Na+-K+-2Cl- cotransporter with differentiation of a human intestinal cell line.
Topics: Adenocarcinoma; Blotting, Northern; Blotting, Western; Butyrates; Butyric Acid; Carrier Proteins; Ce | 1998 |
Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Line; Cell Membrane; Cell Polarity; Colonic Neoplasms; | 1998 |
Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Butyric Acid; Cell Count; Cell Differentiation; Colonic | 2000 |
Sodium butyrate modulates cell cycle-related proteins in HT29 human colonic adenocarcinoma cells.
Topics: Adenocarcinoma; Butyric Acid; Cell Cycle; Cell Cycle Proteins; Cell Division; Colonic Neoplasms; HT2 | 2000 |
Effects of short-chain fatty acids on growth and differentiation of the human colon-cancer cell line HT29.
Topics: Acetates; Acetic Acid; Adenocarcinoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; | 1992 |
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antibodies, Monoclonal; Antigens, Neoplasm; Butyrates; Butyric | 1991 |
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433).
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Bucladesine; Butyrat | 1991 |
Flow cytometric and biochemical analysis of dose-dependent effects of sodium butyrate on human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Cycle; DNA Replication; DNA, Neoplasm; Dose-Response R | 1991 |
Influence of butyrate on lipid metabolism, survival, and differentiation of colon cancer cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Count; Cell Differentiation; Cell Survival; Colonic Ne | 1991 |
[The effects of sodium butyrate (NABT) on fibrillar centres and Ag-staining protein of nucleolus of human stomach glandular carcinoma (MGC-803) cells].
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Nucleolus; Humans; Silver Staining; Stomach Neoplasms; | 1991 |
Ultrastructural differentiation of sodium butyrate-treated human pancreatic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Division; Cell Transformation, N | 1991 |
Role of the extracellular matrix on the growth and differentiated phenotype of murine colonic adenocarcinoma cells in vitro.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Butyrates; Butyric Acid; Cell Differentiation; Coloni | 1991 |
[Effect of sodium butyrate on chromosome number and DNA content of human gastric adenocarcinoma cell line].
Topics: Adenocarcinoma; Aneuploidy; Butyrates; Butyric Acid; Chromosomes, Human; DNA, Neoplasm; Humans; Stom | 1991 |
[Quenching effect and analysis of cell proliferation in dual-laser flow cytometry with human endometrial adenocarcinoma cells in vitro].
Topics: Adenocarcinoma; Benzimidazoles; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Division; DNA, Neop | 1990 |
[The relationship between changes of the steroid receptor and synchronization in human adenocarcinoma cells in vitro of the endometrium].
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Cycle; Cells, Cultured; Charcoal; Culture Media; Dextr | 1985 |
Effects of nucleoside analogs and sodium butyrate on recovery from potentially lethal X ray damage in human colon tumor cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Butyrates; Butyric Acid; Cells, Cultured; Colon; | 1987 |
Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Butyrates; Butyric Acid; Cell Differentiation; Cell L | 1989 |
[The biological effect of sodium butyrate (NaBT) on SGC-7901 cells].
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Division; Cell Membrane; Cyclic AMP; Fibronectins; Hum | 1989 |
Heterogeneity in the induction and expression of carcinoembryonic antigen-related antigens in human colon cancer cell lines.
Topics: Adenocarcinoma; Blotting, Northern; Blotting, Southern; Blotting, Western; Butyrates; Butyric Acid; | 1989 |
Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Butyrates; Butyric Acid; Cell Differentiation; Cell | 1989 |
Butyrate induced reduction of tumor cell laminin receptors.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Gene Expression Regulation | 1986 |
Emergence of differentiated subclones from a human salivary adenocarcinoma cell clone in culture after treatment with sodium butyrate.
Topics: Adenocarcinoma; Animals; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Cycle; Cell Differe | 1986 |
Effects of sodium butyrate on the secretion of beta-2-microglobulin and calcitonin in a human ovarian cancer cell line OC-3-VGH.
Topics: Adenocarcinoma; beta 2-Microglobulin; Butyrates; Butyric Acid; Calcitonin; Cell Division; Cell Line; | 1988 |
Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells.
Topics: Adenocarcinoma; Blotting, Northern; Butyrates; Butyric Acid; Cell Line; Humans; Protein-Tyrosine Kin | 1988 |
Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antigens, Neoplasm; Butyrates; Butyric Acid; Cell Differentiat | 1988 |
Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Carcinoembryonic Antigen; Cell Differentiation; Cell Divisi | 1987 |
Contrasting effects of the differentiating agent sodium butyrate on recovery processes after x-irradiation in heterogeneous human colon tumor cells.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Differentiation; Cell Division; Cell Line; Cell Surviv | 1986 |
Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase.
Topics: Adenocarcinoma; Alkaline Phosphatase; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Colo | 1987 |
Control of growth, morphology, and alkaline phosphatase activity by butyrate and related short-chain fatty acids in the retinoid-responsive 9-1C rat prostatic adenocarcinoma cell.
Topics: Adenocarcinoma; Alkaline Phosphatase; Animals; Butyrates; Butyric Acid; Cell Cycle; Cell Line; Fatty | 1985 |
HCG production of non-trophoblastic cancer cell lines and its modulation by sodium butyrate.
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Carcinoma, Squamous Cell; Cell Line; Chorionic Gonadotropin | 1985 |
Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB).
Topics: Adenocarcinoma; Butyrates; Butyric Acid; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response | 1985 |